Elenco Studi SICOG Chiusi

 

1. Prot. 0109: Fotemustine+dacarbazine versus dacarbazine +/- interferon-alfa in advanced malignant melanoma. A phase III study.

2. Prot. 0401: Oxaliplatin plus Xeloda (OXXEL) versus Oxaliplatin plus folinic acid-modulated 5-Fluorouracil in bolus (OXAFAFU) in metastatic colorectal carcinoma: The COFFEE trial.

3. Prot. 0402: Gemcitabine of paclitaxel and gemcitabine in elderly and fit non-small cell lung cancer patients. A Phase II randomized trial.

4. Studio randomizzato, di fase III, multicentrico, di chemioterapia adiuvante per l'adenocarcinoma dello stomaco o della giunzione gastroesofagea operato radicalmente: confronto di un trattamento sequenziale (CPT-11+5-FU/LV--->TXT+CDDP) versus un regime 5-FU/LV. (INTERGRUPPO NAZIONALE ADIUVANTE GASTRICO)

5. Prot. 0405: Three-drug Regimen (oxaliplatin, levo-folinic acid/5-fluorouracil, and irinotecan) In the carcinoma of the Stomach: The TRIS study. A multicenter phase II trial.

6. Prot. 0505: Gemcitabine and Docetaxel (GEM+DOC) vs Gemcitabine and Paclitaxel (GEM+TAX) as first-line treatment in metastatic breast cancer (MBC) patients with prior exposure to anthracycline-containig chemotherapy. A multicenter randomized phase III study.

7. Prot. 0506: Alimta and Gemcitabine Evaluation in Lung cancer: The ANGEL trial. A Phase II randomized trial.

8. Prot. 0507: Erlotinib or Vinorelbine Evaluation in Non-small cell lung cancer In poor General conditions. The EVENING trial. A Phase II randomized trial.

9. Prot. 0601: Gemcitabine and Docetaxel (GEM+DOC) vs. Doxorubicin and Cyclophosphamide (AC) as first-line treatment in metastatic breast cancer (MBC) patients with No Prior Exposure to anthracycline-containing chemotherapy. A multicenter randomized phase III study. (Prossima attivazione)

10. Prot. 0602: Capecitabine-Vinorelbine or Capecitabine-Docetaxel in elderly breast cancer patients. A SICOG randomized phase II study.

11. Bevacizumab with pelvic Radiotherapy And primary Chemotherapy in Patients with Poor-Risk Rectal Cancer. The BRANCH phase II trial.

12. Prot. 0803 Maintenance and Reinduction chemotherapy with Avastin in metastatic colon cancer: The MARTHA trial.

13. 0802 A Single Arm Clinical Trial to Assess the Efficacy and Safety of Panitumumab (VectibixÒ) in combination with FOLFOX4 Chemotherapy as 1st line treatment in Subject’s with Metastatic Gastric or Gastroesophageal Junction adenocarcinoma (VEGA trial).

 


Aggiornato Aprile 2015